awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33677975-BFE7AD21-39DF-408B-BBBA-0431538A734A
Q33677975-BFE7AD21-39DF-408B-BBBA-0431538A734A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33677975-BFE7AD21-39DF-408B-BBBA-0431538A734A
EGFR Targeting in Hormone-Refractory Prostate Cancer: Current Appraisal and Prospects for Treatment.
P2860
Q33677975-BFE7AD21-39DF-408B-BBBA-0431538A734A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33677975-BFE7AD21-39DF-408B-BBBA-0431538A734A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebf792d6402acc436c3da261a2854a21f8c44e0f
P2860
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.